The data showed that both C-fos and C-jun proteins had higher expression levels around the alveolar septum and the airway in COPD group, while these ascending expression levels were reduced after RLD treatment (P < 0.05). The gene discussed is FOS; the disease is chronic obstructive pulmonary disease.